article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

CRNSV”) was formed by former executives and directors of Nymox Pharmaceutical Corporation (“Nymox” or the “Company”), who were improperly removed from their positions, with a goal to recover shareholder value in Nymox. From 2008 until 2010, Mr. Cutler was President and Chief Executive Officer of Sustainable Power Corp.,

article thumbnail

The Cost of Treating Patients is On the Rise: PwC Goes What’s Behind the 2024 Medical Spending Numbers

Health Populi

The chart on the median price of newly marketed drugs between 2008 and 2002 shows the cost in 2022 reaching $222,000. We’re living in/through and must plan for these ongoing changes, whether we work in provider organizations, health plans, pharma and life science companies, and to be sure, technology and retail/health organizations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

Dr. Fendrick was part of a team that wrote one of the first research articles on the effects of increasing patient cost sharing on health disparities — published in 2008 in the Journal of General Internal Medicine. ” Out of the mouths of Mom’s, right?!

article thumbnail

When sponsored CDS is a crime …

Docnotes

In 2008 I was the CMIO at Allscripts. We had a small team that worked closely with pharmaceutical companies and generated revenue from these relationships. How would the clinician know that this CDS was sponsored by a pharmaceutical company and some other CDS was not? But something didn’t feel right about this.

article thumbnail

The Tech Giants are Coming for Healthcare

Lloyd Price

They are focused on creating strategic partnerships to develop a cross-company strategy for health care and life sciences innovation. Verily Verily, formerly Google Life Sciences, was founded in 2015. Google started a health-records initiative in 2008, but shut it down by 2011, citing poor adoption.